Xenetic Biosciences partner gets Israeli approval for lymphoma study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. DFTX
9. NAVN
10. IBM

Go back to Xenetic Biosciences partner gets Israeli approval for lymphoma study
Xenetic Biosciences, Inc. (NASDAQ: XBIO) Delayed: 2.94 --0 (-0%)
Previous Close $2.94    52 Week High $5.20 
Open $2.94    52 Week Low $0.21 
Day High $2.94    P/E N/A 
Day Low $2.94    EPS $-0.01 
Volume 1,068